المؤلفون: Ouerdani, A, Struemper, H, Suttle, AB, Ouellet, D, Ribba, B

المساهمون: European Union's Seventh Framework Program

المصدر: CPT: Pharmacometrics & Systems Pharmacology ; volume 4, issue 11, page 660-668 ; ISSN 2163-8306 2163-8306

الاتاحة: http://dx.doi.org/10.1002/psp4.12001
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsp4.12001
https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12001
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/psp4.12001

المؤلفون: Hamberg, Paul, Boers-Sonderen, MJ, van der Graaf, WTA, de Bruijn, Peter, Suttle, AB, Eskens, Ferry, Verweij, Jaap, van Herpen, CML, Sleijfer, Stefan

المصدر: Hamberg , P , Boers-Sonderen , MJ , van der Graaf , WTA , de Bruijn , P , Suttle , AB , Eskens , F , Verweij , J , van Herpen , CML & Sleijfer , S 2014 , ' Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I study ' , British Journal of Cancer , vol. 110 , no. 4 , pp. 888-893 . https://doi.org/10.1038/bjc.2013.798

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038601, name=EMC MM-03-86-01, /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038608, name=EMC MM-03-86-08

وصف الملف: application/pdf

الاتاحة: https://pure.eur.nl/en/publications/1d238ff4-ccc3-4aa1-afd2-e307374774e1
https://doi.org/10.1038/bjc.2013.798
https://pure.eur.nl/ws/files/47581506/Repub_58289_O-A.pdf

المؤلفون: Stein, EM, Garcia-Manero, G, Rizzieri, DA, Tibes, R, Berdeja, JG, Savona, MR, Jongen - Lavrencic, Mojca, Altman, JK, Thomson, B, Blakemore, SJ, Daigle, SR, Waters, NJ, Suttle, AB, Clawson, A, Pollock, R, Krivtsov, A, Armstrong, SA, DiMartino, J, Hedrick, E, Löwenberg, Bob, Tallman, MS

المصدر: Stein , EM , Garcia-Manero , G , Rizzieri , DA , Tibes , R , Berdeja , JG , Savona , MR , Jongen - Lavrencic , M , Altman , JK , Thomson , B , Blakemore , SJ , Daigle , SR , Waters , NJ , Suttle , AB , Clawson , A , Pollock , R , Krivtsov , A , Armstrong , SA , DiMartino , J , Hedrick , E , Löwenberg , B & Tallman , MS 2018 , ' The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical ....

مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM024103, name=EMC MM-02-41-03

الاتاحة: https://pure.eur.nl/en/publications/9c1bd56c-0d0b-44a5-98f6-2a79f092a8df
https://doi.org/10.1182/blood-2017-12-818948
http://hdl.handle.net/1765/108946

المؤلفون: Infante JR, NOVELLO, Silvia, Ma WW, Dy GK, Bendell JC, Huff A, Wang Q, Suttle AB, Allen R, Xu CF, Ottesen LH, Burris HA 3rd, Adjei A.A.

المساهمون: Infante JR, Novello S, Ma WW, Dy GK, Bendell JC, Huff A, Wang Q, Suttle AB, Allen R, Xu CF, Ottesen LH, Burris HA 3rd, Adjei AA.

Relation: info:eu-repo/semantics/altIdentifier/pmid/23179337; info:eu-repo/semantics/altIdentifier/wos/WOS:000322333600013; volume:Aug;31(4); issue:---; firstpage:927; lastpage:936; numberofpages:10; journal:INVESTIGATIONAL NEW DRUGS; http://hdl.handle.net/2318/138868; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84880922826

الاتاحة: http://hdl.handle.net/2318/138868
https://doi.org/10.1007/s10637-012-9900-0

المؤلفون: Dy GK, Infante JR, Eckhardt SG, NOVELLO, Silvia, Ma WW, Jones SF, Huff A, Wang Q, Suttle AB, Ottesen LH, Adjei AA, Burris HA 3.r.d.

المساهمون: Dy GK, Infante JR, Eckhardt SG, Novello S, Ma WW, Jones SF, Huff A, Wang Q, Suttle AB, Ottesen LH, Adjei AA, Burris HA 3rd.

Relation: info:eu-repo/semantics/altIdentifier/pmid/23135778; info:eu-repo/semantics/altIdentifier/wos/WOS:000322333600009; volume:31; issue:4; firstpage:891; lastpage:899; numberofpages:9; journal:INVESTIGATIONAL NEW DRUGS; http://hdl.handle.net/2318/1500310; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84880919659

الاتاحة: http://hdl.handle.net/2318/1500310
https://doi.org/10.1007/s10637-012-9887-6

المؤلفون: Dar, MM, Chen, PJ, Curtis, CM, Murphy, PS, Suttle, AB, Arumugham, T, Hodge, JP, Poon, R, Yau, CC

مصطلحات موضوعية: Cytology and histology, Medical sciences, Oncology medical sciences, Radiology and nuclear medicine pharmacy and pharmacology biology

Relation: Journal of Clinical Oncology; The 45th Annual Meeting of the American Society of Clinical Oncology (ASCO 2009), Orlando, FL., 29 May-2 June 2009. In Journal of Clinical Oncology, 2009, v. 27 n. 15 suppl. (May 20), abstract no. 3561; 217024; 15 suppl. (May 20); http://hdl.handle.net/10722/186803; 27

الاتاحة: http://hdl.handle.net/10722/186803

المؤلفون: Kendra KL, Plummer R, Salgia R, O'Brien MER, Paul EM, Suttle AB, Compton N, Xu CF, Ottesen LH, Villalona-Calero MA

المصدر: Molecular Cancer Therapeutics

وصف الملف: application/pdf

Relation: https://eprints.ncl.ac.uk/211833; https://eprints.ncl.ac.uk/fulltext.aspx?url=211833/BBDE1F46-C83F-4BF8-83C8-CCCE13909462.pdf&pub_id=211833

الاتاحة: https://eprints.ncl.ac.uk/211833

المؤلفون: Kendra KL, Plummer R, Salgia R, O'Brien MER, Paul EM, Suttle AB, Compton N, Xu CF, Ottesen LH, Villalona-Calero MA

المصدر: Molecular Cancer Therapeutics

وصف الملف: application/pdf

الاتاحة: https://eprint.ncl.ac.uk/fulltext.aspx?url=211833/BBDE1F46-C83F-4BF8-83C8-CCCE13909462.pdf&pub_id=211833